scispace - formally typeset
V

Vivek M. Rangnekar

Researcher at University of Kentucky

Publications -  122
Citations -  6467

Vivek M. Rangnekar is an academic researcher from University of Kentucky. The author has contributed to research in topics: Apoptosis & Cancer cell. The author has an hindex of 46, co-authored 113 publications receiving 6058 citations. Previous affiliations of Vivek M. Rangnekar include Markey Cancer Center & The Graduate Center, CUNY.

Papers
More filters
Journal ArticleDOI

The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2

TL;DR: The data demonstrate that inhibition of Akt activation may play a crucial role in the induction of apoptosis by celecoxib, supported by studies showing that overexpression of constitutively active Akt protects PC-3 cells from Celecoxib-induced apoptosis.
Journal ArticleDOI

Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease.

TL;DR: It is reported here that Par-4 expression is increased in vulnerable neurons in AD brain and is induced in cultured neurons undergoing apoptosis, and mitochondrial dysfunction and apoptosis exacerbated, in cells expressing presenilin-1 mutations associated with early-onset inherited AD.
Journal Article

Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells

TL;DR: Together, par-1, -3, -4, and -5 represent an apoptosis response gene program common to both androgen-dependent and -independent prostate cells, and are predicted to be important components of diverse effector-driven apoptotic pathways.
Journal ArticleDOI

The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis

TL;DR: Interestingly, extracellular Par-4 induced apoptosis by binding to the stress response protein, glucose-regulated protein-78 (GRP78), expressed at the surface of cancer cells, and activates an extrinsic pathway involving cell surface GRP78 receptor for induction of apoptosis.
Journal ArticleDOI

Suppression of PTEN Expression by NF-κB Prevents Apoptosis

TL;DR: PTEN, a novel target whose suppression is critical for antiapoptosis by NF-κB, is reported here that the tumor suppressor PTEN, which functions as a negative regulator of phosphatidylinositol (PI)-3 kinase/Akt-mediated cell survival pathway, is down regulated by p65 but not by p50.